简介概要

Self-assembled Nanoparticles based on Folic Acid Modifi ed Carboxymethyl Chitosan Conjugated with Targeting Antibody

来源期刊:Journal Of Wuhan University Of Technology Materials Science Edition2016年第2期

论文作者:虎征宇 ZHENG Hua LI Dan XIONG Xiong TAN Mingyuan HUANG Dan GUO Xing 张雪琼 严晗

文章页码:446 - 453

摘    要:Nanoparticles conjugated with antibody were designed as active drug delivery system to reduce the toxicity and side effects of drugs for acute myeloid leukemia(AML).Moreover,methotrexate(MTX)was chosen as modeldrug and encapsulate within folic acid modified carboxymethylchitosan(FACMCS)nanoparticles through self-assembling.The chemicalstructure,morphology,release and targeting of nanoparticles were characterized by routine detection.It is demonstrated that the mean diameter is about 150 nm,the release rate increases with the decreasing of p H,the binding rate of CD33 antibody and FA-CMCS nanoparticles is about 5:2,and nanoparticles can effectively bind onto HL60 cells in vitro.The experimentalresults indicate that the FA-CMCS nanoparticles conjugated with antibody may be used as a potentialp Hsensitive drug delivery system with leukemic targeting properties.

详情信息展示

Self-assembled Nanoparticles based on Folic Acid Modifi ed Carboxymethyl Chitosan Conjugated with Targeting Antibody

虎征宇1,ZHENG Hua1,LI Dan1,XIONG Xiong1,TAN Mingyuan1,HUANG Dan1,GUO Xing1,张雪琼1,严晗2

1. Department of Pharmaceutical Engineering,School of Chemistry,Chemical Engineering and Life Sciences,Wuhan University of Technology2. School of Mechanical and Electronic Engineering,Wuhan University of Technology

摘 要:Nanoparticles conjugated with antibody were designed as active drug delivery system to reduce the toxicity and side effects of drugs for acute myeloid leukemia(AML).Moreover,methotrexate(MTX)was chosen as modeldrug and encapsulate within folic acid modified carboxymethylchitosan(FACMCS)nanoparticles through self-assembling.The chemicalstructure,morphology,release and targeting of nanoparticles were characterized by routine detection.It is demonstrated that the mean diameter is about 150 nm,the release rate increases with the decreasing of p H,the binding rate of CD33 antibody and FA-CMCS nanoparticles is about 5:2,and nanoparticles can effectively bind onto HL60 cells in vitro.The experimentalresults indicate that the FA-CMCS nanoparticles conjugated with antibody may be used as a potentialp Hsensitive drug delivery system with leukemic targeting properties.

关键词:

<上一页 1 下一页 >

有色金属在线官网  |   会议  |   在线投稿  |   购买纸书  |   科技图书馆

中南大学出版社 技术支持 版权声明   电话:0731-88830515 88830516   传真:0731-88710482   Email:administrator@cnnmol.com

互联网出版许可证:(署)网出证(京)字第342号   京ICP备17050991号-6      京公网安备11010802042557号